Finch Therapeutics Group Inc
Change company Symbol lookup
Select an option...
FNCH Finch Therapeutics Group Inc
TDY Teledyne Technologies Inc
TGS Transportadora de Gas del Sur SA
LPRO Open Lending Corp
SLGL Sol Gel Technologies Ltd
UAVS Ageagle Aerial Systems Inc
IWSY ImageWare Systems Inc
AMPX Amprius Technologies Inc
TNC Tennant Co
CVX Chevron Corp

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Finch Therapeutics Group, Inc. is a microbiome technology company with a portfolio of intellectual property and microbiome assets. It is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. It has an intellectual property estate, including more than 70 issued U.S. and foreign patents with relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. The Company’s assets include CP101, an orally administered microbiome candidate designed for the prevention of recurrent C. difficile infection (CDI), with positive clinical data from a Phase II randomized, placebo-controlled trial and a Phase II open-label trial, and pre-clinical assets that are designed to target ulcerative colitis, Crohn’s disease, and autism spectrum disorder. Additionally, it has also developed a biorepository of strains and samples.

Day's Change
-0.009 (-3.10%)
B/A Size
Day's High
Day's Low

Today's volume of 14,683 shares is on pace to be much lighter than FNCH's 10-day average volume of 153,730 shares.


Upcoming Events

FNCH's fiscal year ends in December
There are no upcoming events for FNCH

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
May 10, 2023Q1 2023 Earnings Release-$0.38-$0.09 to -$0.09--
March 23, 2023Q4 2022 Earnings Release-$0.56-$0.34 to -$0.34-$0.40
November 10, 2022Q3 2022 Earnings Release-$0.85-$0.42 to -$0.38-$0.21
August 11, 2022Q2 2022 Earnings Release-$0.48-$0.46 to -$0.37-$0.32

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.